Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • milesgr
    Member
    • Jun 2010
    • 34

    #1

    GATK variant calling statistics...

    Hi all,
    We are calling variants on partial exome data using GATK. We want to see what fraction of our samples have a particular variant. As constituted, GATK will give us the set of samples containing the particular variant. Any sample that doesn't will simply exclude it from the VCF. My question is whether or not there is a way to distinguish the samples that have a true wild-type phenotype (and thus no variant call) from those that aren't called due to poor quality score (and thus should be excluded from our percentages since the phenotype cannot be determined). Thank you very much in advance for your help.
  • vdauwera
    Member
    • Apr 2012
    • 43

    #2
    There are two ways to deal with this. One is to use the EMIT_ALL_SITES option of UnifiedGenotyper and enable calculation of reference PLs. The other, which is better, is to call variants with HalpotypeCaller (GATK's newer variant caller) and use the -ERC option to generate a gVCF.

    For more details, see the online GATK documentation and please post any follow-up questions on the GATK support forum.

    http://www.broadinstitute.org/gatk/guide/
    http://gatkforums.broadinstitute.org/

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2





      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification,...
      10-30-2026, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 11-05-2026, 09:25 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 11-03-2026, 11:54 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    101 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    58 views
    0 reactions
    Last Post SEQadmin2  
    Working...